Annual Report 2014

DIRECTORS’ REPORT

The Directors present the annual report and audited consolidated financial statements of the Group for the year ended 28 February 2014.

PRINCIPAL ACTIVITIES+-

The Group’s principal trading activity is the production, marketing and selling of cider and beer, wine, soft drinks and bottled water.

The Company announced on 7 March 2013 that the Group had completed the acquisition of M. & J. Gleeson (Investments) Limited and its subsidiaries, a supplier and distributor of beverages in Ireland.

During the year the Group also acquired the whole of the issued share capital of Latin American Holdings Limited, together with its subsidiary Biofun-Produtos Biológicas do Fundão, Lda, a Portuguese manufacturer of apple juice concentrate.

Subsequent to the year-end, the Company announced on 18 March 2014 that the Group had acquired the outstanding balance of the ordinary share capital of Wallaces Express Limited, a wholesaler of beverages in Scotland, not already owned by it.

There has been no other material change in the nature of the business of the Group.

RESULTS+-

For the year ended 28 February 2014, the Group reported Revenue of €912.9 million (2013: €724.1million) and Net Revenue of €620.2million (2013: €476.9 million).

Operating profit before exceptional items amounted to €126.7 million (2013: €114.6 million (restated)). This was in line with guidance given by the Company during the year that operating profit would be in the range of €125.0 million to €132.0 million.

Profit for the year attributed to equity shareholders amounted to €83.3 million (2013: €89.4 million (restated)). On this basis, basic earnings per share amounted to 24.7c (2013: 27.2c per share (restated)) and diluted earnings per share amounted to 24.3c (2013: 26.6c per share (restated)).

Earnings excluding exceptional items amounted to €101.1million (2013: €93.7 million (restated)). On this basis, adjusted basic earnings per share amounted to 30.0c (2013: 28.5c per share restated) and adjusted diluted earnings per share amounted to 29.5c (2013: 27.9c per share restated).

The financial statements for the year ended 28 February 2014 are set out in this section.

DIVIDENDS+-

An interim dividend of 4.3 cent per share for the year ended 28 February 2014 was paid on 23 December 2013. Subject to approval at the Annual General Meeting, it is proposed to pay a final ordinary dividend of 5.7 cent per share for the year ended 28 February 2014 to shareholders who are registered at close of business on 30 May 2014.

BOARD OF DIRECTORS+-

Emer Finnan was appointed as a Director with effect from 1 May 2014. Since 15 May 2013, the date of the last Directors’ Report, no other change has occurred in the composition of the Board.

The names, functions and date of appointment of the current Directors, who give the responsibility statement on this page, are as follows:

Director

Function

Appointment

Sir Brian Stewart

Chairman

2010

Stephen Glancey

Group Chief Executive Officer

2008

Kenny Neison

Group Chief Financial Officer

2009

Joris Brams

Executive Director

2012

Emer Finnan

Non-executive

2014

Stewart Gilliland

Non-executive

2012

John Hogan

Non-executive

2004

Richard Holroyd

Non-executive

2004

Breege O’Donoghue

Non-executive

2004

Anthony Smurfit

Non-executive

2012

Short biographical notes on each current Director are given on this page.

In line with the provisions of the UK Corporate Governance Code, C&C Group is adopting a policy of annual re-election for all Board Directors. Consequently, all Directors will offer themselves for election or re-election at the Company’s Annual General Meeting to be held on 3 July 2014.

INTERESTS OF DIRECTORS AND COMPANY SECRETARY+-

Information in relation to the beneficial and non-beneficial interests in the share capital of Group companies held by the Directors and Company Secretary who held office at 28 February 2014 is contained within the Report of the Remuneration Committee on Directors’ Remuneration on this page.

RESEARCH AND DEVELOPMENT+-

Certain Group undertakings are engaged in ongoing research and development aimed at improving processes and expanding product ranges.

FURTHER INFORMATION ON THE GROUP+-

The information required by section 13 of the Companies (Amendment) Act 1986 (as amended) to be included in this report with respect to:

(a) the review of the development and performance of the business and future developments is set out in the Operations Review and the Strategic Report;

(b) the principal risks and uncertainties which the Company and the Group face is set out in the Strategic Report on this page;

(c) the key performance indicators relevant to the business of the Group, including environmental and employee matters, is set out in the Strategic Report on this page and in the Group Chief Financial Officer’s review; and further information in respect of environmental and employee matters is set out in in the Report on Corporate Responsibility on this page;

(d) the financial risk management objectives and policies of the Company and the Group, including hedging activities and the exposure of the Company and the Group to financial risk, is set out in the Group Chief Financial Officer’s Review and note 23 to the financial statements.

ACCOUNTING RECORDS+-

The measures taken by the Directors to secure compliance with the requirements of Section 202 of the Companies Act, 1990 with regard to the keeping of proper books of account are to employ accounting personnel with appropriate expertise and to provide adequate resources to the finance function. The books of account of the Company are maintained at Group offices in Parkwest Business Park, Dublin.

POLITICAL DONATIONS+-

No political donations were made by the Group during the year that require disclosure in accordance with the Electoral Acts, 1997 to 2002.

CORPORATE GOVERNANCE+-

The corporate governance statement of the Company for the year, including the main features of the internal control and risk management systems of the Group, is contained in the Directors’ Statement on Corporate Governance on this page .

DIRECTORS’ REMUNERATION+-

The Report of the Remuneration Committee on Directors’ Remuneration, including the Company’s policy on Directors’ remuneration, is set out on this page. The Board will present this report and the policy to shareholders at the Annual General Meeting for the purposes of non-binding advisory votes.

SUBSTANTIAL HOLDINGS+-

The table below shows all notified shareholdings in excess of 3% of the issued ordinary share capital of the Company as at 28 February 2014 and 20 May 2014.

No. of ordinary shares held as notified at
28 February 2014

% at
28 February 2014

No. of ordinary shares held as notified at
20 May 2014

% at 20 May 2014

Franklin Templeton Institutional, LLC

32,771,380

9.45%

32,771,380

9.45%

Franklin Templeton Investment Management Limited

24,251,710

6.99%

24,251,710

6.99%

Invesco Limited

17,319,433

4.99%

17,319,433

4.99%

OppenheimerFunds, Inc.

17,135,344

4.94%

10,046,565

2.90%

Schroder Investment Management Limited

14,392,561

4.15%

14,392,561

4.15%

FMR LLC

13,941,078

4.02%

13,941,078

4.02%

Investec Asset Management Limited

13,852,110

3.99%

18,853,073

5.44%

Prudential plc Group of Companies

13,803,563

3.98%

13,803,563

3.98%

Oppenheimer International Growth Fund*

13,653,936

3.94%

10,167,806

2.93%

F&C Asset Management plc

13,185,114

3.80%

13,185,114

3.80%

FIL Limited

n/a

Less than 3%

12,033,328

3.47%

Wellington Management Company, LLP

10,661,806

3.07%

10,661,806

3.07%

*OppenheimerFunds, Inc. has notified the Company that the holding of Oppenheimer International Growth Fund is included within the holding of OppenheimerFunds, Inc.

As far as the Company is aware, other than as stated below, no other person or company had at 28 February 2014 or 20 May 2014 an interest in 3% or more of the share capital of the Company.

SHARE PRICE+-

The price of the Company’s ordinary shares as quoted on the Irish Stock Exchange at the close of business on 28 February 2014 was €4.922 (28 February 2013: €4.895 ). The price of the Company’s ordinary shares ranged between €3.750 and €5.187 during the year.

AUDITOR+-

In accordance with Section 160(2) of the Companies Act, 1963, the auditor, KPMG, Chartered Accountants, Statutory Audit Firm, will continue in office.

ISSUE OF SHARES AND PURCHASE OF OWN SHARES+-

At the Annual General Meeting held on 3 July 2013, the Directors received a general authority to allot shares. A limited authority was also granted to Directors to allot shares for cash otherwise than in accordance with statutory pre-emption rights. Resolutions will be proposed at the Annual General Meeting to be held on 3 July 2014 to allot shares to a nominal amount which is equal to approximately one-third of the issued ordinary share capital of the Company. In addition, a resolution will also be proposed to allow the Directors allot shares for cash otherwise than in accordance with statutory pre-emption rights up to an aggregate nominal value which is equal to approximately 5% of the nominal value of the issued share capital of the Company, and in the event of a rights issue. If granted, these authorities will expire at the conclusion of next year’s Annual General Meeting or 3 October 2015, whichever is the earlier. The Directors have currently no intention to issue shares pursuant to these authorities except for issues of ordinary shares under the Company’s share option plans and the Company’s scrip dividend scheme.

At the Annual General Meeting held on 3 July 2013 authority was granted to purchase up to 10% of the Company’s Ordinary Shares. No shares were purchased by the Company in the year under review.

Special resolutions will be proposed at the Annual General Meeting to be held on 3 July 2014 to renew the authority of the Company, or any of its subsidiaries, to purchase up to 10% of the Company’s Ordinary Shares in issue at the date of the Annual General Meeting and in relation to the maximum and minimum prices at which treasury shares (effectively shares purchased and not cancelled) may be re-issued off-market by the Company. If granted, the authorities will expire on the earlier of the date of the Annual General Meeting in 2015 and the date 18 months after the passing of the resolution. The minimum price which may be paid for shares purchased by the Company shall not be less than the nominal value of the shares and the maximum price will be 105% of the average market price of such shares over the preceding five days. The Directors will only exercise the power to purchase shares if they consider it to be in the best interests of the Company and its shareholders.

Options to subscribe for a total of 3,050,693 Ordinary Shares are outstanding, representing 0.88% of the issued ordinary share capital. If the authority to purchase Ordinary Shares were used in full, the options would represent 0.98% of the issued ordinary share capital.

DILUTION LIMITS AND TIME LIMITS+-

All employee share plans with the exception of the Joint Share Ownership Plan, which was specifically approved by shareholders in December 2008, contain the share dilution limits recommended in institutional guidance, namely that no awards shall be granted which would cause the number of Shares issued or issuable pursuant to awards granted in the ten years ending with the date of grant, but excluding awards granted on or prior to admission to the Irish Stock Exchange in 2004, (a) under any discretionary or executive share scheme adopted by the Company (other than the Joint Share Ownership Plan) to exceed 5 per cent., and (b) under any employees’ share scheme adopted by the Company (other than the Joint Share Ownership Plan) to exceed 10 per cent., of the ordinary share capital of the Company in issue at that time.

In the ten year period up to the date of this report, commitments to issue new shares or re-issue treasury shares under discretionary share schemes (net of lapsed and forfeited commitments and excluding the Joint Share Ownership Plan which was specifically approved by shareholders in December 2008) amounted to 2.42% of the Company’s issued ordinary share capital as at the date of this report. No additional commitments to issue shares have been made under non-discretionary schemes.

The European Communities (Takeover Bids (Directive 2004/25/EC)) Regulations 2006+-

Structure of the Company’s share capital

At 20 May 2014 the Company has an issued share capital of 346,840,406 ordinary shares of €0.01 each and an authorised share capital of 800,000,000 ordinary shares of €0.01 each.

At 28 February 2014 and at the date of this report the trustee of the C&C Employee Trust held 7,582,841 ordinary shares of €0.01 each in the capital of the Company, including shares held jointly by it under the terms of the C&C Joint Share Ownership Plan (further information on which is contained in note 5 (Share Based Payments) to the financial statements. Shares held by the trustee of the C&C Employee Trust are accounted for as if they were treasury shares. These shares are, however, included in the calculation of Total Voting Rights for the purposes of Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007.

Details of employee share schemes, and the rights attaching to shares held in these schemes, can be found in note 5 (Share Based Payments) to the financial statements and the Report of the Remuneration Committee on Directors’ Remuneration on this page. Details of the rights attaching to shares issued under the Joint Share Ownership Plan are set out in note 5 (Share Based Payments) to the financial statements.

The Company has no securities in issue conferring special rights with regard to control of the Company.

Details of persons with a significant holding of securities in the Company are set out on this page.

Rights and obligations attaching to the Ordinary Shares

All Ordinary Shares rank pari passu, and the rights attaching to the Ordinary Shares (including as to voting and transfer) are as set out in the Company’s articles of association (“Articles”). A copy of the Articles may be obtained on request to the Company Secretary.

Holders of Ordinary Shares are entitled to receive duly declared dividends in cash or, when offered, additional Ordinary Shares. In the event of any surplus arising on the occasion of the liquidation of the Company, shareholders would be entitled to a share in that surplus pro rata to their holdings of Ordinary Shares.

Holders of Ordinary Shares are entitled to receive notice of and to attend, speak and vote in person or by proxy, at general meetings having, on a show of hands, one vote, and, on a poll, one vote for each Ordinary Share held. Procedures and deadlines for entitlement to exercise, and exercise of, voting rights are specified in the notice convening the general meeting in question. There are no restrictions on voting rights except in the circumstances where a “Specified Event” (as defined in the Articles) shall have occurred and the Directors have served a Restriction Notice on the shareholder. Upon the service of such Restriction Notice, no holder of the shares specified in the notice shall, for so long as such notice shall remain in force, be entitled to attend or vote at any general meeting, either personally or by proxy.

Holding and transfer of Ordinary Shares

The Ordinary Shares may be held in either certificated or uncertificated form (through CREST). Save as set out below, there is no requirement to obtain the approval of the Company, or of other shareholders, for a transfer of Ordinary Shares. The Directors may decline to register (a) any transfer of a partly-paid share to a person of whom they do not approve, (b) any transfer of a share to more than four joint holders, and (c) any transfer of a certificated share unless accompanied by the share certificate and such other evidence of title as may reasonably be required. The registration of transfers of shares may be suspended at such times and for such periods (not exceeding 30 days in each year) as the Directors may determine.

Transfer instruments for certificated shares are executed by or on behalf of the transferor and, in cases where the share is not fully paid, by or on behalf of the transferee. Transfers of uncertificated shares may be effected by means of a relevant system in the manner provided for in the Companies Act, 1990 (Uncertificated Securities) Regulations, 1996 (the “CREST Regulations”) and the rules of the relevant system. The Directors may refuse to register a transfer of uncertificated shares only in such circumstances as may be permitted or required by the CREST Regulations.

Rules concerning the appointment and replacement of the Directors and amendment of the Company’s Articles

Unless otherwise determined by ordinary resolution of the Company, the number of Directors shall not be less than two or more than 14. Subject to that limit, the shareholders in general meeting may appoint any person to be a Director either to fill a vacancy or as an additional Director. The Directors also have the power to co-opt additional persons as Directors, but any Director so co-opted is under the Articles required to be submitted to shareholders for re-election at the first annual general meeting following his or her co-option.

The Articles require that at each annual general meeting of the Company one-third of the Directors retire by rotation. However, in accordance with the recommendations of the UK Corporate Governance Code, the Directors have resolved they will all retire and submit themselves for re-election by the shareholders at the Annual General Meeting to be held this year.

The Company’s Articles may be amended by special resolution (75% majority of votes cast) passed at general meeting.

Powers of Directors

Under its Articles, the business of the Company shall be managed by the Directors, who exercise all powers of the Company as are not, by the Companies Acts or the Articles, required to be exercised by the Company in general meeting.

The powers of Directors in relation to issuing or buying back by the Company of its shares are set out above under “Issue of Shares and Purchase of Own Shares”.

Miscellaneous

Certain of the Group’s borrowing facilities include provisions that, in the event of a change of control of the Company, could oblige the Group to repay the facilities. Certain of the Company’s customer and supplier contracts and joint venture arrangements also contain provisions that would allow the counterparty to terminate the agreement in the event of a change of control of the Company, but none of these are considered to be significant in terms of their potential impact on the business of the Group as a whole. The Company’s Executive Share Option Scheme and Long Term Incentive Plan each contain change of control provisions which allow for the acceleration of the exercise of share options/awards in the event of a change of control of the Company.

There are no agreements between the Company and its Directors or employees providing for compensation for loss of office or employment (whether through resignation, purported redundancy or otherwise) that occurs because of a takeover bid in excess of their normal contractual entitlement.

ANNUAL GENERAL MEETING+-

Your attention is drawn to the letter to shareholders and the notice of meeting accompanying this report which set out details of the matters which will be considered at the Annual General Meeting.

Signed

On behalf of the Board

Sir B Stewart

S Glancey

Chairman

Group Chief Executive Officer

20 May 2014